Medications

FDA defends approval of controversial Alzheimer's drug

The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.

Alzheimer's disease & dementia

Imbalance in gum bacteria linked to Alzheimer's disease biomarker

Older adults with more harmful than healthy bacteria in their gums are more likely to have evidence for amyloid beta—a key biomarker for Alzheimer's disease—in their cerebrospinal fluid (CSF), according to new research ...

Alzheimer's disease & dementia

Women accumulate Alzheimer's-related protein faster

Alzheimer's disease seems to progress faster in women than in men. The protein tau accumulates at a higher rate in women, according to research from Lund University in Sweden. The study was recently published in Brain.

page 23 from 38